Cargando…
Lipocalin 2 as a potential systemic biomarker for central serous chorioretinopathy
No systemic biomarker of Central Serous Chorioretinopathy (CSCR) has been identified. Lipocalin 2 (LCN2 or NGAL), alone or complexed with MMP-9 (NGAL/MMP-9), is increased in several retinal disorders. Serum levels of LCN2 and NGAL/MMP-9 were measured in CSCR patients (n = 147) with chronic (n = 76)...
Autores principales: | Matet, A., Jaworski, T., Bousquet, E., Canonica, J., Gobeaux, C., Daruich, A., Zhao, M., Zola, M., Meester-Smoor, M., Mohabati, D., Jaisser, F., Yzer, S., Behar-Cohen, F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677530/ https://www.ncbi.nlm.nih.gov/pubmed/33214636 http://dx.doi.org/10.1038/s41598-020-77202-y |
Ejemplares similares
-
High Levels of C-Reactive Protein with Low Levels of Pentraxin 3 as Biomarkers for Central Serous Chorioretinopathy
por: Bousquet, Elodie, et al.
Publicado: (2023) -
ACUTE CENTRAL SEROUS CHORIORETINOPATHY: Factors Influencing Episode Duration
por: Daruich, Alejandra, et al.
Publicado: (2017) -
Risk of Recurrence and Transition to Chronic Disease in Acute Central Serous Chorioretinopathy
por: Mohabati, Danial, et al.
Publicado: (2020) -
Ocular steroidome in human eyes and in eyes with complex central serous chorioretinopathy (CSCR)
por: Zola, Marta, et al.
Publicado: (2023) -
Oral Mineralocorticoid-Receptor Antagonists: Real-Life Experience in Clinical Subtypes of Nonresolving Central Serous Chorioretinopathy With Chronic Epitheliopathy
por: Daruich, Alejandra, et al.
Publicado: (2016)